Search
for
Sort by
Research 151–180 of 1000+
- MK-386, an Inhibitor of 5α-Reductase Type 1, Reduces Dihydrotestosterone Concentrations in Serum and Sebum without Affecting Dihydrotestosterone Concentrations in Semen<sup>1</sup>
- Molecular interactions of progesterone derivatives with 5α-reductase types 1 and 2 and androgen receptors
- Cutaneous features of myotonic dystrophy types 1 and 2: Implication of premature aging and vitamin D homeostasis
- Synthesis and activity of 8-substituted benzo[c]quinolizin-3-ones as dual inhibitors of human 5α-reductases 1 and 2
- Multi-target evaluation of Korean herbal compounds against the SRD5A2 / AR / beta-catenin axis for androgenetic alopecia: Boltz-2 cofold, ChEMBL-anchored ranking, ADMET-AI 107-endpoint safety panel, and pilosebaceous single-cell atlas-constrained prioritization of Saponin Re, Emodin, and Biochanin A
- 1424 METHYLATION AND DECREASED EXPRESSION OF 5-ALPHA REDUCTASE 2 IN HUMAN PROSATE SAMPLES: IMPLICATIONS FOR RESISTANCE TO THERAPY FOR BPH
- Distinct use of super-enhancer elements controls cell type–specific CD25 transcription and function
- The synthesis of (−)-4-methyl-8-chloro-trans-1,2,3,4,4a,5,6,10b-octahydrobenzo-[f]-quinolin-3-one-[3-14C] (LY300502-14C]) via a circuitous route
- Finasteride Induces Epigenetic Alteration of TMPRss2 Gene Expression: A Potential role in Severe Acute Respiratory Syndrome-Corona Virus-2 Inhibition
- A rare case of Vitamin D dependent rickets type II: a case report
- Testosterone Deficiency is Not Protective Against the Development of Adenocarcinoma of the Prostate in a Type 1 Diabetic Patient
- Selective non-steroidal inhibitors of 5α-reductase type 1
- Referee report. For: Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved]
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
- Polycystic ovary syndrome
- The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
- Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
- 5α-reductase activity in the prostate
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- The Human Sebocyte Culture Model Provides New Insights into Development and Management of Seborrhoea and Acne
- Sebocytes are the Key Regulators of Androgen Homeostasis in Human Skin
- Dihydrotestosterone and the Concept of 5α–Reductase Inhibition in Human Benign Prostatic Hyperplasia
- Metabolic risk in PCOS: phenotype and adiposity impact
- Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study